• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. OMNILINK ELITE; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. OMNILINK ELITE; STENT, ILIAC Back to Search Results
Model Number 1012631-39
Medical Device Problem Codes Entrapment of Device (1212); Stretched (1601); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/27/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to a right common iliac artery.The 8.0x39mm omnilink elite peripheral stent system failed to crossed the lesion due to interaction with a previously implanted stent.Resistance was felt during removal of the delivery system as the stent was noted to be hooked on the previously implanted stent.The stent elongated and a sheath was advanced to unhook the stent.Another same size omnilink elite stent was used to complete the procedure.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
A visual inspection was performed on the returned device.The reported stent stretching and stent dislodgement were confirmed.The reported failure to advance and entrapment of the device could not be replicated in a testing environment as it was related to operational context of the procedure.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.Based on the reported information and the observations from the returned analysis, the investigation determined that the reported issue and treatment appears to be related to circumstances of the procedure.Based on the results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
Subsequently, after the initial was filed it was noted that during removal the stent had dislodged as it was hooked on a previously implanted stent.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE
Common Device Name
STENT, ILIAC
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20453848
Report Number2024168-2024-12149
Device Sequence Number21005063
Product Code NIO
UDI-Device Identifier08717648178511
UDI-Public(01)08717648178511(17)261231(10)3071141
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P110043
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1012631-39
Device Catalogue Number1012631-39
Device Lot Number3071141
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/27/2024
Supplement Date Received by Manufacturer11/12/2024
Initial Report FDA Received Date10/15/2024
Supplement Report FDA Received Date11/13/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/11/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexMale
Patient Weight83 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-